Breast cancer is the second most common cancer in women worldwide, with an estimated 2.3 million new cases diagnosed in 2020 alone. With such a high incidence, finding ways to prevent breast cancer is of utmost importance.

While there are various lifestyle changes you can make to reduce your risk, such as maintaining a healthy weight and exercising regularly, there are also medications available that can help lower your risk. In this article, we will discuss different medications that have been shown to reduce the risk of breast cancer.

Tamoxifen

Tamoxifen is a medication that has been shown to reduce the risk of both invasive and non-invasive breast cancer in women at high risk of developing the disease.

The drug works by blocking estrogen receptors in breast cells, which can slow or stop the growth of cancer. Studies have found that tamoxifen can reduce the risk of breast cancer by as much as 50% in high-risk women.

However, tamoxifen does come with risks of its own, including an increased risk of blood clots, stroke, and endometrial cancer.

Therefore, before considering tamoxifen as a prevention option, it’s important to discuss the potential benefits and risks with your doctor.

Raloxifene

Raloxifene is a medication similar to tamoxifen that is also used to prevent breast cancer. Like tamoxifen, raloxifene works by blocking estrogen receptors in breast cells.

Studies have found that raloxifene can reduce the risk of invasive breast cancer by as much as 44% in postmenopausal women at high risk of developing the disease.

Raloxifene also comes with potential side effects, including an increased risk of blood clots and hot flashes. Again, it’s important to discuss the benefits and risks of raloxifene with your doctor before considering it as a prevention option.

Related Article Shield yourself from breast cancer: Prescription medications that help

Aromatase Inhibitors

Aromatase inhibitors are a class of medications that block the production of estrogen in postmenopausal women.

By reducing the amount of estrogen in the body, aromatase inhibitors can help prevent the growth of breast cancer cells that are fueled by estrogen. Studies have found that aromatase inhibitors can reduce the risk of breast cancer by as much as 65% in women at high risk of developing the disease.

Like tamoxifen and raloxifene, aromatase inhibitors also come with risks, including an increased risk of osteoporosis and joint pain. Again, it’s important to discuss the potential benefits and risks of aromatase inhibitors with your doctor.

Chemoprevention Cocktail

In addition to single medications, researchers have also studied a combination of medications that may offer even greater breast cancer prevention benefits.

A study conducted by the National Surgical Adjuvant Breast and Bowel Project (NSABP) found that taking a combination of tamoxifen and raloxifene for five years reduced the risk of invasive breast cancer by 65% in postmenopausal women at high risk of developing the disease.

Another study, conducted by the Women’s Health Initiative, found that postmenopausal women who took a combination of aromatase inhibitors and another medication called exemestane for five years had a 65% reduction in breast cancer risk.

Conclusion

While no preventative measure is 100% effective, taking medication to reduce breast cancer risk can be an effective option for women at high risk of developing the disease.

However, all medications come with potential risks, and it’s important to discuss the potential benefits and risks of each medication with your doctor to determine the best prevention approach for you.